Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relativistic Lévy processes.

Physical review. E·2025
Same author

Use of latex microbeads for detection of Plasmodium vivax lactate dehydrogenase using flow cytometry.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2025
Same author

Author Correction: Generalization to d-dimensions of a fermionic path integral for exact enumeration of polygons on hypercubic lattices.

Scientific reports·2024
Same author

Intermediate statistics: Addressing the thermoelectric properties of solids.

Physical review. E·2024
Same author

Generalization to d-dimensions of a fermionic path integral for exact enumeration of polygons on hypercubic lattices.

Scientific reports·2024
Same author

The use of Artificial Intelligence in predicting Respiratory Syncytial Virus-inhibiting flavonoids.

Brazilian journal of biology = Revista brasleira de biologia·2023

Related Experiment Video

Updated: May 16, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Alzheimer random walk model: two previously overlooked diffusion regimes.

J C Cressoni1, G M Viswanathan, A S Ferreira

  • 1Departamento de Física e Química, FCFRP, Universidade de São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.

Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|December 11, 2012
PubMed
Summary
This summary is machine-generated.

This study explores the Alzheimer walk, a memory-influenced random walk model. New diffusion phases with specific Hurst exponents were discovered, enriching the model's complex phase diagram.

More Related Videos

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Related Experiment Videos

Last Updated: May 16, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Area of Science:

  • Statistical Physics
  • Complex Systems Analysis
  • Stochastic Processes

Background:

  • The Alzheimer walk is a non-Markovian random walk model exhibiting memory-controlled diffusion.
  • This model displays long-range correlations and a rich variety of diffusive regimes, including superdiffusion.
  • Superdiffusion in this model arises from both memory and memory loss.

Purpose of the Study:

  • To analyze the phase diagram of the Alzheimer walk model, identifying all diffusion regimes and critical lines.
  • To review existing numerical and analytical estimations of the Hurst exponent for this model.
  • To report the discovery of two new phases: evanescent log-periodic diffusion and log-periodic diffusion with escape.

Main Methods:

  • Theoretical modeling of a non-Markovian one-dimensional random walk.
  • Phase diagram analysis to identify diffusion regimes and critical lines.
  • Review and analysis of Hurst exponent values.

Main Results:

  • The study identified two previously overlooked phases: evanescent log-periodic diffusion and log-periodic diffusion with escape.
  • Both newly identified phases are characterized by a Hurst exponent H=1/2.
  • Evanescent log-periodic diffusion shows damped log-periodicity, while log-periodic diffusion with escape exhibits a diverging first moment.

Conclusions:

  • The discovery of these new phases significantly enriches the complex phase diagram of the Alzheimer walk.
  • The findings contribute to understanding phase transitions, aging phenomena, and symmetry breaking in complex systems.
  • The results highlight the nuanced role of memory and memory loss in generating anomalous diffusion.